Cargando…

Modeling Structure–Activity Relationship of AMPK Activation

The adenosine monophosphate activated protein kinase (AMPK) is critical in the regulation of important cellular functions such as lipid, glucose, and protein metabolism; mitochondrial biogenesis and autophagy; and cellular growth. In many diseases—such as metabolic syndrome, obesity, diabetes, and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Drewe, Jürgen, Küsters, Ernst, Hammann, Felix, Kreuter, Matthias, Boss, Philipp, Schöning, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587902/
https://www.ncbi.nlm.nih.gov/pubmed/34770917
http://dx.doi.org/10.3390/molecules26216508
_version_ 1784598290862440448
author Drewe, Jürgen
Küsters, Ernst
Hammann, Felix
Kreuter, Matthias
Boss, Philipp
Schöning, Verena
author_facet Drewe, Jürgen
Küsters, Ernst
Hammann, Felix
Kreuter, Matthias
Boss, Philipp
Schöning, Verena
author_sort Drewe, Jürgen
collection PubMed
description The adenosine monophosphate activated protein kinase (AMPK) is critical in the regulation of important cellular functions such as lipid, glucose, and protein metabolism; mitochondrial biogenesis and autophagy; and cellular growth. In many diseases—such as metabolic syndrome, obesity, diabetes, and also cancer—activation of AMPK is beneficial. Therefore, there is growing interest in AMPK activators that act either by direct action on the enzyme itself or by indirect activation of upstream regulators. Many natural compounds have been described that activate AMPK indirectly. These compounds are usually contained in mixtures with a variety of structurally different other compounds, which in turn can also alter the activity of AMPK via one or more pathways. For these compounds, experiments are complicated, since the required pure substances are often not yet isolated and/or therefore not sufficiently available. Therefore, our goal was to develop a screening tool that could handle the profound heterogeneity in activation pathways of the AMPK. Since machine learning algorithms can model complex (unknown) relationships and patterns, some of these methods (random forest, support vector machines, stochastic gradient boosting, logistic regression, and deep neural network) were applied and validated using a database, comprising of 904 activating and 799 neutral or inhibiting compounds identified by extensive PubMed literature search and PubChem Bioassay database. All models showed unexpectedly high classification accuracy in training, but more importantly in predicting the unseen test data. These models are therefore suitable tools for rapid in silico screening of established substances or multicomponent mixtures and can be used to identify compounds of interest for further testing.
format Online
Article
Text
id pubmed-8587902
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85879022021-11-13 Modeling Structure–Activity Relationship of AMPK Activation Drewe, Jürgen Küsters, Ernst Hammann, Felix Kreuter, Matthias Boss, Philipp Schöning, Verena Molecules Article The adenosine monophosphate activated protein kinase (AMPK) is critical in the regulation of important cellular functions such as lipid, glucose, and protein metabolism; mitochondrial biogenesis and autophagy; and cellular growth. In many diseases—such as metabolic syndrome, obesity, diabetes, and also cancer—activation of AMPK is beneficial. Therefore, there is growing interest in AMPK activators that act either by direct action on the enzyme itself or by indirect activation of upstream regulators. Many natural compounds have been described that activate AMPK indirectly. These compounds are usually contained in mixtures with a variety of structurally different other compounds, which in turn can also alter the activity of AMPK via one or more pathways. For these compounds, experiments are complicated, since the required pure substances are often not yet isolated and/or therefore not sufficiently available. Therefore, our goal was to develop a screening tool that could handle the profound heterogeneity in activation pathways of the AMPK. Since machine learning algorithms can model complex (unknown) relationships and patterns, some of these methods (random forest, support vector machines, stochastic gradient boosting, logistic regression, and deep neural network) were applied and validated using a database, comprising of 904 activating and 799 neutral or inhibiting compounds identified by extensive PubMed literature search and PubChem Bioassay database. All models showed unexpectedly high classification accuracy in training, but more importantly in predicting the unseen test data. These models are therefore suitable tools for rapid in silico screening of established substances or multicomponent mixtures and can be used to identify compounds of interest for further testing. MDPI 2021-10-28 /pmc/articles/PMC8587902/ /pubmed/34770917 http://dx.doi.org/10.3390/molecules26216508 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Drewe, Jürgen
Küsters, Ernst
Hammann, Felix
Kreuter, Matthias
Boss, Philipp
Schöning, Verena
Modeling Structure–Activity Relationship of AMPK Activation
title Modeling Structure–Activity Relationship of AMPK Activation
title_full Modeling Structure–Activity Relationship of AMPK Activation
title_fullStr Modeling Structure–Activity Relationship of AMPK Activation
title_full_unstemmed Modeling Structure–Activity Relationship of AMPK Activation
title_short Modeling Structure–Activity Relationship of AMPK Activation
title_sort modeling structure–activity relationship of ampk activation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587902/
https://www.ncbi.nlm.nih.gov/pubmed/34770917
http://dx.doi.org/10.3390/molecules26216508
work_keys_str_mv AT drewejurgen modelingstructureactivityrelationshipofampkactivation
AT kustersernst modelingstructureactivityrelationshipofampkactivation
AT hammannfelix modelingstructureactivityrelationshipofampkactivation
AT kreutermatthias modelingstructureactivityrelationshipofampkactivation
AT bossphilipp modelingstructureactivityrelationshipofampkactivation
AT schoningverena modelingstructureactivityrelationshipofampkactivation